Addus HomeCare (ADUS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock ma ...

On Wall Street, small-cap stocks often present unique opportunities for significant growth. These under-the-radar companies are typically not as well-known or widely covered by analysts as their large-cap counterparts. Yet, they can deliver jumbo-sized gains that may far outstrip the market average. Moreover, small-cap stocks or exchange-traded funds (ETFs), such as the Vanguard Small-Cap ETF (NYSEARCA:VB), that focus on small-caps can help provide portfolio diversification.Academic research suggests that s ...

Believes Enhabit's Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP ("AREX Capital Management" or "we"), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE:EHAB) (the "Company" or "Enhabit"), today issued the below statement ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34504 ADDUS HOMECARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 20-5340172 (State or oth ...

After navigating a tough pandemic era, the outpatient and home healthcare industry has been seeing steady growth on the back of innovation in services. The industry includes companies that offer ambulatory care in an outpatient setting or at home. They use advanced medical technologies for diagnosis, treatment, and rehabilitation services. These players are operators of HMO medical centers, kidney dialysis centers and other outpatient care centers.Meanwhile, Wall Street regained momentum in first week of Ma ...

For the quarter ended March 2024, Addus HomeCare (ADUS) reported revenue of $280.75 million, up 11.6% over the same period last year. EPS came in at $1.21, compared to $0.97 in the year-ago quarter.The reported revenue represents a surprise of +1.16% over the Zacks Consensus Estimate of $277.52 million. With the consensus EPS estimate being $1.10, the EPS surprise was +10.00%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...

Addus HomeCare (ADUS) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10%. A quarter ago, it was expected that this provider of home-based personal care, nursing and rehabilitative therapy services would post earnings of $1.16 per share when it actually produced earnings of $1.32, del ...

[First Quarter 2024 Financial Results](index=1&type=section&id=First%20Quarter%202024%20Financial%20Results) [First Quarter 2024 Highlights](index=1&type=section&id=First%20Quarter%202024%20Highlights) Addus HomeCare reported strong Q1 2024 financial results, with net service revenues up 11.6% and Adjusted EBITDA up 24.6% Q1 2024 Key Financial Metrics (vs. Q1 2023) | Metric | Q1 2024 | Q1 2023 | Change | | :--- | :--- | :--- | :--- | | Net Service Revenues | $280.7M | $251.6M | +11.6% | | Net Income | $15.8M | $12.7M | +24.4% | | Net Income per Diluted Share | $0.97 | $0.78 | +24.4% | | Adjusted EBITDA | $32.4M | $26.0M | +24.6% | | Adjusted Net Income per Diluted Share | $1.21 | $0.97 | +24.7% | | Cash Flow from Operations | $38.7M | $18.8M | +105.9% | [Management Commentary and Segment Performance](index=1&type=section&id=Management%20Commentary%20and%20Segment%20Performance) Management attributed strong performance to solid execution and demand, with Personal Care driving growth and Hospice improving - The Personal Care segment, representing **74.1%** of the business, saw a **9.3%** same-store revenue increase year-over-year, driven by steady volume and rate increases in certain states[4](index=4&type=chunk) - The company has experienced a more stable labor environment and improved ability to hire and retain caregivers due to investments in efficient hiring and scheduling systems[4](index=4&type=chunk) - The Hospice segment, now **20.0%** of the business, achieved **5.8%** organic revenue growth, benefiting from a **3.1%** rate increase and the acquisition of Tennessee Quality Care, with improved volume trends[5](index=5&type=chunk) [Financial Condition and Outlook](index=2&type=section&id=Financial%20Condition%20and%20Outlook) [Cash, Liquidity, and Outlook](index=2&type=section&id=Cash%2C%20Liquidity%2C%20and%20Outlook) The company maintained strong liquidity with significant cash and available credit, prioritizing accretive acquisitions for strategic growth Liquidity Position as of March 31, 2024 | Metric | Amount | | :--- | :--- | | Cash | $76.7M | | Bank Debt | $101.4M | | Revolving Credit Facility Capacity | $486.9M | | Availability under Credit Facility | $377.5M | - Net cash from operating activities was **$38.7 million** for Q1 2024, enabling a **$25.0 million** reduction of the revolver balance[6](index=6&type=chunk)[7](index=7&type=chunk) - The company's primary strategic objective is to pursue accretive acquisitions that enhance personal care services, build scale, or add complementary clinical services, with a focus on markets that support value-based contracting[7](index=7&type=chunk) [Financial Statements](index=4&type=section&id=Financial%20Statements) [Condensed Consolidated Statements of Income](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) Addus reported Q1 2024 net service revenues of $280.7 million, with gross profit and net income showing increases Q1 2024 Income Statement Highlights (in thousands) | Metric | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | Net service revenues | $280,746 | $251,599 | | Gross profit | $88,177 | $78,415 | | Operating income | $23,645 | $18,608 | | Net income | $15,830 | $12,675 | | Net income per diluted share | $0.97 | $0.78 | [Condensed Consolidated Balance Sheets](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2024, total assets reached $1.014 billion, with increased equity and stable liabilities Balance Sheet Summary (in thousands) | Metric | March 31, 2024 | March 31, 2023 | | :--- | :--- | :--- | | Total current assets | $191,847 | $209,210 | | Total assets | $1,014,000 | $931,083 | | Total liabilities | $288,857 | $282,197 | | Total stockholders' equity | $725,143 | $648,886 | [Net Service Revenue by Segment](index=6&type=section&id=Net%20Service%20Revenue%20by%20Segment) In Q1 2024, Personal Care was the largest segment at $208.0 million, with all segments showing revenue growth Net Service Revenue by Segment (in thousands) | Segment | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | Personal Care | $208,003 | $190,032 | | Hospice | $55,863 | $49,082 | | Home Health | $16,880 | $12,485 | | **Total Revenue** | **$280,746** | **$251,599** | [Key Statistical and Financial Data](index=7&type=section&id=Key%20Statistical%20and%20Financial%20Data) Q1 2024 saw Personal Care revenue per hour increase, Hospice organic revenue grow, and Home Health organic revenue decline Q1 2024 Key Segment Metrics (vs. Q1 2023) | Segment & Metric | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | **Personal Care** | | | | Revenue per billable hour | $27.35 | $24.98 | | Organic Revenue Growth | 9.3% | 11.4% | | **Hospice** | | | | Patient days | 305,630 | 287,551 | | Revenue per patient day | $182.78 | $176.22 | | Organic Revenue Growth | 5.8% | 2.6% | | **Home Health** | | | | Total Volume | 8,055 | 5,442 | | Organic Revenue Growth | (15.1)% | 13.8% | [Reconciliation of Non-GAAP Financial Measures](index=8&type=section&id=Reconciliation%20of%20Non-GAAP%20Financial%20Measures) The company provides non-GAAP reconciliations, detailing adjustments from Net Income to Adjusted EBITDA and Adjusted Net Income Reconciliation of Net Income to Adjusted EBITDA (Q1 2024, in thousands) | Description | Amount | | :--- | :--- | | Net income | $15,830 | | (+) Interest expense, net | $2,335 | | (+) Income tax expense | $5,480 | | (+) Depreciation and amortization | $3,469 | | (+) Acquisition expenses | $2,711 | | (+) Stock-based compensation expense | $2,618 | | **Adjusted EBITDA** | **$32,443** | Reconciliation of Net Income to Adjusted Net Income (Q1 2024, in thousands) | Description | Amount | | :--- | :--- | | Net income | $15,830 | | (+) Acquisition expenses | $2,711 | | (+) Stock-based compensation expense | $2,618 | | (-) Tax effect | ($1,370) | | **Adjusted Net Income** | **$19,789** |

Company Performance - Addus HomeCare (ADUS) has returned 6% year-to-date, outperforming the Medical sector average of 2.3% [2] - The Zacks Consensus Estimate for ADUS' full-year earnings has increased by 2.8% over the past three months, indicating improved analyst sentiment [2] - Addus HomeCare holds a Zacks Rank of 2 (Buy), suggesting a positive outlook for the stock [1][2] Industry Comparison - Addus HomeCare is part of the Medical - Outpatient and Home Healthcare industry, which has gained an average of 4.7% year-to-date [3] - HCA Healthcare (HCA), another outperforming stock in the Medical sector, has returned 14.3% year-to-date and belongs to the Medical - Hospital industry, which has increased by 14.9% [2][3] - The Medical sector ranks 4 in the Zacks Sector Rank, reflecting the overall strength of the industry [1]

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven ...